Volker Arndt

Has grant

Group leader

Deutsches Krebsforschungszentrum
Country flagGermany

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Cancer survivorship and quality of life in long-term survivors of colorectal, breast and prostate cancer

Open Date: 2008-10-01

Close Date: 2012-06-01

Articles (22)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Purpose This systematic review aims to summarize the associations between combined healthy lifestyles and psychosocial outcomes (health-related quality of life (HRQOL), depression, anxiety, psychological distress (PD), and posttraumatic stress disorder (PTSD)) among cancer survivors. Methods PubMed, Web of Science, Cochrane Library, and EMBASE were searched for observational and interventional studies examining healthy lifestyle scores (HLS, calculated by a combination of at least three lifestyles) and psychosocial outcomes among cancer survivors from inception to April 2024. A minimum of two studies with the same study design were pooled using random effects models. Results Twenty-one studies (44,812 survivors) were included. Of all studies, 16 of which were included in meta-analysis. The pooling of cross-sectional evidence shows significant association between HLS and overall, physical, and psychosocial HRQOL. Significance was only observed for overall and physical HRQOL but not for psychosocial HRQOL in cohort studies. The estimations and 95% confidence interval (CI) with 1-point increase in HLS were 1.47 (0.83–2.12) and 1.42 (0.19–2.65) for overall and physical HRQOL, respectively. The evidence from interventional studies also indicated that interventions on multiple lifestyles have positive effects on the physical but not psychosocial HRQOL. Despite the limited number of studies, significant associations were found between HLS and depression, anxiety, PD, and PTSD. Conclusions Although evidence is limited, we found that the combination of multiple healthier lifestyles is associated with better psychosocial outcomes in cancer survivors. Implications for cancer survivors This review underscores the potential for adhering to multiple healthy lifestyles to improve psychosocial outcomes and enhance HRQOL for cancer survivors.

Year:

2026

Year:

2026

With improved survival, noncancer causes of death have become increasingly relevant in cancer care. Excess noncancer mortality may reflect treatment-related toxicity, comorbidities, shared risk factors, and psychologic distress. This scoping review aimed to map the population-based evidence on the causes of death in patients with cancer and identify research gaps. PubMed, Web of Science, Cochrane Library, EMBASE, and Scopus were searched until April 2025. A total of 203 population-based studies using standardized mortality ratios (SMR) to compare cause-specific mortality among patients with cancer with that of the general population were included. Noncancer mortality was consistently elevated among patients with cancer [median SMR 1.60; interquartile range (IQR) 1.24–2.51], especially during the first year after diagnosis (3.42; 1.45–6.92), and remained higher over 10 years after diagnosis (1.51; 1.08–5.49). Younger patients and those with advanced-stage cancers demonstrated higher noncancer mortality. Among specific causes, cardiovascular disease (1.37; 1.09–2.34), suicide (1.73; 1.32–2.77), stroke (1.36; 0.98–2.17), infectious diseases in general (2.20; 1.35–4.16), septicemia (2.84; 1.64–5.47), and pneumonia/influenza (1.57; 1.08–2.69) were consistently elevated. Patients with cancer have demonstrated substantial noncancer mortality. These findings identify priority areas for targeted prevention and further investigation into cause-specific mortality patterns beyond cancer-related deaths to improve outcomes.

Year:

2026

Prostate cancer accounts for the largest group of cancer survivors in men. Hormone therapy is essential, especially in advanced disease. While its short-term effects are well studied, research into the long-term effects on health-related quality of life (HRQOL) remains limited. Therefore, this review aims to synthesize and identify key gaps in the literature on HRQOL and symptom burden in long-term prostate cancer survivors who underwent hormone therapy. After searching four databases until 15 April 2025, we identified 14 observational studies that reported on general and prostate cancer-specific HRQOL in prostate cancer survivors ≥ 5 years post-diagnosis. Survivors who underwent hormone therapy reported worse global health status and physical, emotional, and social functioning compared to those treated with local therapies like prostatectomy or radiation. These survivors also experienced greater symptom burdens, alongside worse vitality and mental health. Prostate cancer-specific issues, such as bowel and urinary bother and sexual dysfunction, were also more pronounced in hormone therapy recipients. Nevertheless, outcomes beyond 15 years remain under-researched. The findings of this review highlight the importance of discussing long-term HRQOL compromises with patients who consider hormone therapy. However, they warrant cautious interpretation, particularly due to limited details on hormone therapy regimens and inadequate control for stage.

Year:

2026

PurposeThe European Oncology Quality of Life (EUonQoL) project aims to develop a questionnaire toolkit (EUonQoL-Kit) to assess the quality of life (QoL) of cancer patients and survivors across Europe.MethodsThe EUonQoL-Kit development used mixed-methods and a co-design approach. Data was collected in six countries (Denmark, France, Germany, Italy, Netherlands and UK). The target populations were patients in active treatment (A), survivors (B) and patients requiring palliative care (C). A review of existing QoL theoretical models produced an initial EUonQoL conceptual framework. Semi-structured interviews and a Delphi survey evaluated/modified the framework. Existing validated items were used to construct the toolkit, including Computer Adaptive Testing (CAT), where available. A usability study evaluated EUonQoL-Kit.v1. Data triangulation and consensus methodology guided EUonQoL-Kit.v2.ResultsThe initial conceptual framework covered four multi-dimensional domains: physical, social and overall health, and psychological wellbeing. The interviews and Delphi survey included 75 and 155 participants, respectively. The domain ‘healthcare experience’ was identified and included in the framework. EUonQoL-Kit.v1 resulted in three static questionnaires, one for each target population (n items- A=75; B=67; C=79). Following usability testing with 53 participants, EUonQoL-Kit.v2 was produced via a multi-stakeholder consensus development panel, creating a shortened version (n items- A=50; B=50; C=44). Dynamic versions of these questionnaires were developed using the EORTC CAT Core system.ConclusionsEUonQoL-Kit is a novel toolkit developed to assess QoL across the cancer continuum and inform health policy within Europe. Its psychometric properties are currently being evaluated using data collected on more than 4200 patients across 32 countries.

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (66)

Emiel J. Krahmer

The Netherlands Cancer Institute

NETHERLANDS
View details

Li Hsu

Fred Hutchinson Cancer Research Center

UNITED STATES
View details

Polly Newcomb

University of Washington

UNITED STATES
View details

Sven Voigtländer

Senior Researcher

University Medical Center of the Johannes Gutenberg University Mainz

GERMANY
View details

Galina Velikova

-

UNITED KINGDOM
View details

Marc Gunter

International Agency for Research on Cancer

FRANCE
View details

Alice Nennecke

Head

-

GERMANY
View details

Tabitha Harrison

Fred Hutchinson Cancer Research Center

UNITED STATES
View details

Konstantinos K. Tsilidis

-

UNITED KINGDOM
View details

Sara Alfieri

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY
View details

Mogens Grønvold

Københavns Universitet

DENMARK
View details

Victor Moreno

Professor

University of Barcelona

SPAIN
View details

Marina Evangelou

Senior Lecturer in Statistics

Imperial College London

UNITED KINGDOM
View details

Fränzel J.B. van Duijnhoven

Wageningen University & Research

NETHERLANDS
View details

Luana Caselli

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY
View details

Susanna Larsson

Professor at Karolinska Institutet

Karolinska Institutet

SWEDEN
View details

Juan Pablo Lewinger

Associate Professor

University of Southern California

UNITED STATES
View details

SAM Gernaat

Universitair Medisch Centrum Utrecht

NETHERLANDS
View details

Bernhard Holzner

Prof

Medical University of Innsbruck

AUSTRIA
View details

David Drew

Assistant Professor of Medicine

Massachusetts General Hospital

UNITED STATES
View details

Ulrike Peters

Fred Hutchinson Cancer Research Center

UNITED STATES
View details

Matthew Devall

Assistant Professor

University of Virginia

UNITED STATES
View details

Sophia Harlid

Umea University

SWEDEN
View details

Eric Kawaguchi

Assistant Professor

University of Southern California

UNITED STATES
View details

Julie R Palmer

Boston University School of Medicine

UNITED STATES
View details

Meeke Hoedjes

Tilburg University

NETHERLANDS
View details

Elizabeth Platz

Professor

Johns Hopkins University

UNITED STATES
View details

Mariana C. Stern

Professor

University of Southern California

UNITED STATES
View details

Augusto Caraceni

Professore associato

Università degli Studi di Torino

ITALY
View details

Tim Bishop

University of Leeds

UNITED KINGDOM
View details

Stéphane Bézieau

Université de Nantes

FRANCE
View details

Virginia Díez-Obrero

Vrije Universiteit Amsterdam

NETHERLANDS
View details

Hongmei Nan

Professor

University of Indianapolis

UNITED STATES
View details

Emmanouil Bouras

Research associate

Imperial College London

UNITED KINGDOM
View details

Alicja Wolk

Professor of Nutritional Epidemiology

Karolinska Institutet

SWEDEN
View details

Anna H. Wu

Professor

University of Southern California

UNITED STATES
View details

John Potter

Professor

University of Washington

UNITED STATES
View details

Bethany Van Guelpen

Umea University

SWEDEN
View details

Li Li

University of Virginia

UNITED STATES
View details

Andrea Gsur

Medical University of Vienna

AUSTRIA
View details

Helle Pappot

University of Copenhagen

DENMARK
View details

Loic Le Marchand

Professor

University of Hawaii

UNITED STATES
View details

Edward A. Ruiz-Narváez

Associate Professor

University of Michigan School of Public Health

UNITED STATES
View details

Elom K Aglago

Imperial College London

UNITED KINGDOM
View details

Christian H. Brandts

Professor & Director

Goethe University Frankfurt

GERMANY
View details

Claudio Lombardo

Università degli Studi di Bologna Dipartimento di Fisica e Astronomia

ITALY
View details

David Conti

Professor

Colorado School of Public Health

UNITED STATES
View details

Cinzia Brunelli

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY
View details

W. James Gauderman

professor

University of Southern California

UNITED STATES
View details

Paul Pharoah

Professor of Cancer Epidemiology

Cedars-Sinai Medical Center

UNITED STATES
View details

Graham Casey

University of Virginia

UNITED STATES
View details

Catherine Tangen

Fred Hutchinson Cancer Research Center

UNITED STATES
View details

Kala Visvanathan

Professor

Johns Hopkins University

UNITED STATES
View details

Alexandra Gilbert

University of Leeds

UNITED KINGDOM
View details

Daniel D. Buchanan

Senior Research Fellow

University of Melbourne

AUSTRALIA
View details

Montserrat Ferrer

Associate lecturer

Universitat Pompeu Fabra

SPAIN
View details

Stephen Gruber

Professor

City Of Hope National Medical Center

UNITED STATES
View details

Leslye Rojas-Concha

Senior researcher and project leader

Københavns Universitet

DENMARK
View details

Anshul Kundaje

Associate Professor

Stanford University

UNITED STATES
View details

Mark Jenkins

University of Melbourne

AUSTRALIA
View details

Peter T. Campbell

Professor

Albert Einstein College of Medicine

UNITED STATES
View details

Graham Giles

Head of Research

-

AUSTRALIA
View details

Michael Hoffmeister

Professor of Epidemiology, Group leader, Deputy divison head

German Cancer Research Center (DKFZ)

GERMANY
View details

Elizabeth Barry

Associate Professor

Dartmouth College Geisel School of Medicine

UNITED STATES
View details

Pavel Vodička

senior researcher

Charles University

CZECH REPUBLIC
View details

Jennifer Ose

Professorin (W2)

Hochschule Hannover

GERMANY
View details